Steps Toward Adapting Physical Activity Guidelines for the Lower Mississippi Delta Population (STEPS)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01264757|
Recruitment Status : Completed
First Posted : December 22, 2010
Last Update Posted : February 5, 2016
|Condition or disease||Intervention/treatment||Phase|
|Physical Inactivity||Behavioral: Physical Activity Educational Materials Behavioral: Pedometer||Early Phase 1|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||43 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Steps Toward Adapting Physical Activity Guidelines for the Lower Mississippi Delta Population|
|Study Start Date :||February 2010|
|Actual Primary Completion Date :||June 2010|
|Actual Study Completion Date :||June 2010|
Active Comparator: Education
Educational brochure about physical activity provided.
Behavioral: Physical Activity Educational Materials
A brochure was provided to participants about the health benefits of physical activity and physical activity recommendations
A pedometer was provided in addition to educational materials.
A pedometer was provided to participants in addition to educational materials about the health benefits of physical activity.
- Minutes spent in moderate-to-vigorous physical activity (MVPA) [ Time Frame: The primary outcome is measured at baseline and after a 7-day intervention period (1 week) ]A GT3X accelerometer is used to monitor each participants physical activity levels for seven consecutive days at baseline and again following a 7-day intervention period. The amount of time per day spent above a threshold of 2200 accelerometer counts/min is averaged over at least three days as the measure of MVPA.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01264757
|United States, Louisiana|
|Pennington Biomedical Research Center|
|Baton Rouge, Louisiana, United States, 70808|
|Principal Investigator:||Peter T Katzmarzyk, PhD||Pennington Biomedical Research Center|